Skip to main content

Pliant Therapeutics Inc. Common Stock (PLRX)

About The Company

PLRX Stock Market Logo

Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.

IPO Year Sector Industry
2020 Health Care Biotechnology: Pharmaceutical Preparations

Pliant Therapeutics Inc. (PLRX) Latest News

Company Contact & Address (PLRX)

Corporate Headquarters Phone Website
United States
+1 650 481-6770 Official PLRX Website

PLRX Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ PLRX

Jobs & Employment at Pliant Therapeutics Inc.

LinkedIn Company Page
Official Career & Employment Page Careers, Jobs & Employment at Pliant Therapeutics Inc. (PLRX)

Related & Similar Stock Symbols

RFM Stock Market Price & News


RiverNorth Flexible Municipal Income Fund Inc. Common …

BV Stock Market Price & News


BrightView Holdings Inc. Common Stock

RCLFU Stock Market Price & News


Rosecliff Acquisition Corp I Unit